Halozyme Therapeutics shares owned by Caas Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Caas Capital Management
from 13F filings
Historical chart of Caas Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Caas Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $300k | 4.7k | 63.81 |